lung-abscess. Dr ibrahimi md pulmonologist.ppt

AliusmanMahmoodi 16 views 72 slides Mar 10, 2025
Slide 1
Slide 1 of 72
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71
Slide 72
72

About This Presentation

Lung abscess


Slide Content

Lung abscess
Pleural empyema
Tuberculosis
Janusz Kowalewski, MD, PhD.
Department and Clinic of Thoracic Surgery
Faculty of Medicine
Nicolaus Copernicus University in Toruń

DEFINITION:
Lung abscess 
(Latin: 
abscessus) is a collection
of
 pus that has built up within the
lung tissue. 
This is usually caused by a
 bacterial infection
. .
Lung abscess

-Diabetes
-Neoplastic disease
Alcohol abuse
-Malnutrition
-Narcotics abuse
-Immunosupression
-HIV infection
-Older age
Lung absces: predisposing factors:

Lung abscess (chest X-ray)

Staphylococcus pneumoniaStaphylococcus pneumonia

ETIOLOGY:

Aerobic bacteria infection (streptococcus (streptococcus
pneumoniae, streptococcus pyogenes, staphylococus aereus, pneumoniae, streptococcus pyogenes, staphylococus aereus,
klebsiella pneumonie, pseodomonas aeruginosa, proteus klebsiella pneumonie, pseodomonas aeruginosa, proteus
vulgaris, escherichia coli, neisseria meningitidis, haemophillus vulgaris, escherichia coli, neisseria meningitidis, haemophillus
influenzae)influenzae)
Anaerobic bacteria infectionbacteria infection
(clostridium hystoliticum, bacteroides fragilis).(clostridium hystoliticum, bacteroides fragilis).
Mixed bacterial flora ( common) ( common)
Fungal infections

Protozoa infections Protozoa infections (entamoeba histolytica)
Lung abscess (abscessus pulmonis)
The most
common

Streptococcus pneumoniaeStreptococcus pneumoniae

Staphylococcus aureusStaphylococcus aureus

Classification:
PRIMARY ABSCESS:
In healthy lung parenchyma
(anaerobic aspiration,
specific pneumonia)
SECONDARY ABSCESS :
In lung tissue affected by: existing lung disease, metastatic
tumors, lung carcinoma, foreign body, infarction,emphysema.
Lung abscess (abscessus pulmonis)

Lung abscessLung abscess
•Clinical signs ?Clinical signs ?

CLINICAL SIGNS :
 Hectic fever, Hectic fever,
 chills, chills,
 cough, cough,
 expectoration, expectoration,
 chest pain, chest pain,
 weight loss, weight loss,
 dyspnoea dyspnoea
 hemoptysishemoptysis
Lung abscess (abscessus pulmonis)

Lung absces (diagnosis) ?Lung absces (diagnosis) ?

Diagnosis:
 clinical signs,

 chest X-ray,
 CT scan,
 bronchoscopy,
 sputum analysis
 (BAL)
 CRP, OB, WBC elevation
Lung absces (abscessus pulmonis)

Bad prognostic factors:
 big abscess,
 right lower lobe,
 bad general condition (anemia, hipoproteinemia,
alcohol abuse, narcotics abuse),
 pathogenic bacteria:
- Pseudomonas aeruginosa – mortality rate: app. 83%,
- Staphylococus aureus – mortality rate: app. 50%.
- Klebsiella pneumoniae -44%).
(Boaz Hirshberg,  Miri Sklair-Levi,  Ran Nir-Paz,  Liat Ben-Sira,  et
al. Factors predicting mortality of patients with lung abscess
Chest. Chicago: Mar 1999. Vol.115,  Iss. 3;  pg. 746, 5 pgs)
Lung abscess (abscessus pulmonis)

LOCAL COMPLICATIONS:
 Spread to the healthy lung tissue,
 Pleural empyema,
 Broncho-pleural fistula,
 Phlegmon of the chest wall,
 Major hemoptysis,
 Aspergilloma.
Lung abscess (abscessus pulmonis)

General complicatons:
 bacterial endocarditis,

 multifocal liver abscess,
 multifocal brain abscess,
 nephritis, amyloidosis,
 sepsis,
 multi-organ failure
Mortality rate: 15%-20%
(Bartlett JG. Lung abscess. In: Baum GL, Wolinsky E, eds. Textbook of pulmonary
diseases. 5th ed. Boston, MA: Little, Brown and Company, 2007; 607-620. )
Lung abscess (abscessus pulmonis)

Conservative treatment ???:
Antibiotics based on drug sensitivity-
6-8 weeks
Supported by chest physiotherapy and
bronchoscopic aspiration
Lung abscess (abscessus pulmonis)

THERAPY:
It is thought that lung abscess in its early stage can regress
spontaneously in approximately 20-30% of cases.
If conservative treatment is ineffective or complications are observed
adequate invasive or surgical treatment should be initiated.
It is estimated that invasive treatment by intercostal tube drainage or
surgery is indispensable in 11-12% of patients in whom antibiotic
therapy was ineffective.
(Estrera AS, Platt MR, Mills LJ, et al. Primary lung abscess. J
Thorac Cardiovasc Surg 1980; 79:275-282).
Lung abscess (abscessus pulmonis)

INVASIVE THERAPY:
INJECTION OF THERAPEUTIC AGENTS DIRECTLY INTO AN ABSCESS
CAVITY:
The abscess is punctured through the chest wall and antibiotics are injected directly
into its cavity. This method is suitable for large peripheral abscesses where the
visceral and parietal pleura are accreted. The method is burdened with a risk of
pneumothorax or empyema formation.
ENDOSCOPIC ABSCESS EVACUATION:
If lung abscess is a result of pathology of the bronchial tree with its obstruction and
retention of septic debris within bronchi distally to the level of obstruction
bronchoscopy is an effective technique for abscess evacuation. The abscess
evacuation can be completed by the injection of antibiotic into the abscess cavity.
Lung abscess (abscessus pulmonis)

INVASIVE MANAGEMENT:
CAVERNOSTOMY:
A method used in selected cases of lung abscess (Monaldi procedure). Obliteration
of the pleural cavity is an indispensable condition to perform this procedure. Short
fragments of two or three ribs are resected over a place where the distance between
an abscess capsule and the chest wall is the shortest. The surface of the lung is
visualized and the abscess cavity is opened. Then the abscess cavity is packed with
gauze saturated with an antiseptic solution. The gauze is changed regularly for
several weeks until the process of healing and contraction of a lung defect is
obtained.
PERCUTANEOUS CATHETER DRAINAGE
Percutaneous catheter drainage of lung abscess under fluoroscopic or computed
tomography guidance is a technique introduced into medical practice during last
three decades and brings relatively good results in selected cases. The limitation of
this method is a localization of an abscess near important anatomical structures that
makes an introduction of a catheter hazardous. The technique is burdened with some
serious complications such as pneumothorax accompanied by a brocho-pleural
fistula, pleural empyema, hemorrhage and cardiac arrest.
Lung abscess (abscessus pulmonis)

Lung abscess drainage Lung abscess drainage

INVASIVE MANAGEMENT:
ENDOSCOPIC DRAINAGE:
This technique is suitable for lung abscesses having a contact with the
bronchus. A flexible bronchoscope is introduced into the bronchial tree with its
end-part as close as possible to an abscess cavity. Then a guide-wire is inserted
through a bronchoscope tool channel under fluoroscopic guidance directly into
the abscess cavity. When fluoroscopy shows that the guide-wire is in a proper
position a 90 cm long 7F catheter (pigtail catheter - Cordis; Miami, FL) is
introduced along the guide-wire into the abscess cavity. To check a proper
position of the catheter a non-barite contrast medium ( Isovist-300) can be
injected into the abscess cavity through this catheter. The proximal end of the
catheter is brought out through the nostril. The method enables the evacuation
of liquid content of abscess and abscess cavity irrigation with antibiotic or
antifungal (Amphotericin B) solutions. The catheter is kept within the abscess
cavity from 3 to 21 days. The technique offers gradual sterilization and
obliteration of abscess .
Lung abscess (abscessus pulmonis)

Surgical treatment:
Method: RESECTION.
Indications: ???
Mortality rate: 11%-28%.
Lung abscess (abscessus pulmonis)

Surgicasl treatment - INDICATIONS:
 Massive hemoptysis,
 Pleural empyema,
 Bronchopleural fistula,
 Conservative treatment failure,
 Foreign body,
 Big abscess (big cavity, >6cm after 8 weeks of treatment),
 Cancer suspicion.
Lung abscess (abscessus pulmonis)

Surgical treatment:

METHODS:
Wedge resection:
Anatomical resections: (segmentectomy, lobectomy,
pneumonectomy)
Lung cancer (abscessus pulmonis)

METHODS OF SURGICAL TREATMENT:

A type of resection of pulmonary parenchyma is dependent on localization
and size of abscess and a patient’s general state.
NON-ANATOMICAL LUNG RESECTION
Marginal or wedge pulmonary parenchyma resection for abscesses using
linear staplers: TA and GIA type is effective for small lesions localized
peripherally.
ANATOMICAL LUNG RESECTION
Large lung abscesses, abscesses localized deeply in pulmonary parenchyma
and multiple lung abscesses are all indications for anatomical resections. The
most frequent procedures are resections of a pulmonary lobe (lobectomy) or
resection of two pulmonary lobes of the right lung (bilobectomy). In the cases
of solitary abscess or multiple abscesses with vast destruction of the lung the
resection of the whole lung (pneumonectomy) is sometimes necessary. Local
conditions rarely enable less extensive surgical procedures such as
semisegmentectomy or bisegmentectomy.
Lung abscess (abscessus pulmonis)

METHODS OF SURGICAL TREATMENT :

VATS (Video Assisted Thoracic Surgery)
A method that is a combination of minithoracotomy and videothoracoscopic
technique (video telescope and endoscopic instruments). It enables resection of
some small, peripherally localized abscesses.
DECORTICATION + LUNG RESECTION
A method used for the treatment of lung abscesses accompanied by pleural
empyema. Decortication consists in the removal of a thick fibrinopurulent
coat from the lung surface. Besides it the part of a pleural empyema capsule
that covers the internal surface of the chest wall is also resected along with the
parietal pleura. The procedure is completed by resection of pulmonary
parenchyma with abscess.
LUNG RESECTION + IRRIGATING DRAINAGE
A procedure used in the cases of lung abscess coexisting with acute pleural
empyema. When pulmonary parenchyma with lung abscess is resected two or
three tubes are introduced into the pleural cavity and continuous irrigating
drainage with antibiotic or antiseptic solution is carried out.
Lung abscess (abscessus pulmonis)

PLEURAL EMPYEMA (empyema pleurae)
Pleural empyema is a kind of exudative pleuritis caused by
Microorganisms (bacteria, fungi, some protozoa) that infected
the pleural cavity.
Inflammation of organs or anatomical structures localized within the chest
and out of its anatomical borders can caused a retention of effusion in the
pleural space (hydrothorax)
A reason for pleural effusions are also systemic diseases. Initially sterile
exudate can be resorbed by the pleura if a primary disease is treated effectively.
The infection of the exudate causes its transformation into purulent liquid that
fills the pleural cavity and forms pleural empyema (empyema pleurae).

PLEURAL EMPYEMA (empyema pleurae)
Pleural effusion infected by: bacteria,
fungi,
protozoa.

PLEURAL EMPYEMA (empyema pleurae)
CLINICAL CONDITIONS CAUSING LIQUID RETENTION IN THE
PLEURAL CAVITY :
 TRANSUDATE - circulatory insufficiency, hepatic cirrhosis, nephrotic
syndrome, superior vena caval obstruction.
 EXUDATE – malignancy, infection, pulmonary embolism, esophageal
perforation, pancreatitis, sarcoidosis, systemic diseases.
 LYMPH (chylothorax) – trauma, surgery, malignancy, subclavian vein
thrombosis.
 BLOOD (haemothorax) - trauma, malignancy
In a case when a liquid collected in the pleural space becomes infected
by virulent microorganisms it transforms into pus.
Pleural empyema can develop in any individual but it seems to be more
frequent in younger people in whom immune system is weakened.

Left pleural effusionLeft pleural effusion

Right hydro-pneumothoraxRight hydro-pneumothorax

Pleural empyemaPleural empyema
CTCT

Pleural empyema: causes
1OthersOthers
< 1Complications of parasitic infectionsComplications of parasitic infections
< 1Bronchopleural fistula (spontaneus Bronchopleural fistula (spontaneus
pneumothorax)pneumothorax)
8-11Intraabdominal abscessIntraabdominal abscess
25Surgical procedures: lungs, esophagus, Surgical procedures: lungs, esophagus,
mediastinummediastinum
3-5Thoracic traumaThoracic trauma
1MycosisMycosis
1TuberculosisTuberculosis
1-3SepsisSepsis
1-3Lung abscessLung abscess
50 PneumoniaPneumonia
%%Causes Causes

Pleural empyema (empyema pleurae)
Etiology:
 pneumococus
 staphylococus
 streptococus
 haemophilus influenzae
 Gram-negative bacteria (pseudomonas, klebsiella, enterobacteriace,
escherichia coli)
 anaerobes

Pleural empyema (empyema pleurae)
PATOPHYSIOLOGY – the way of contamination :
 Direct way (thoracic wall): trauma, pleural puncture, drainage
( 25% of all empyemas): FROM OUTSIDE
 FROM INSIDE – pneumonia,
lung abscess, bronchiectases, mediastinitis,
intraabdominal abscess.
 Hematogenic way
 Lymphagenic way

PLEURAL EMPYEMA (empyema pleurae)
PATHOPHYSIOLOGY
PHASES OF PLEURAL EMPYEMA FORMATION :
 Serous phase (exudative empyema): clear, straw-colored effusion
(pH>7.3, glucose concentration [GLU]>60 mg%, lactate
dehydrogenase activity [LDH] < 500 U/L )
 Fibrinopurulent phase (fibrinopurulent empyema): effusion contains
large numbers of bacteria and polymorphonuclear granulocytes,
intensification of clinical signs and symptoms of inflammation,
deposition of fibrin on both the visceral and parietal pleura
( pH < 7,1, GLU < 40mg%, LDH > 1000 U/L)
 Organizing empyema phase (organizing empyema) (fibrothorax) –
nonelastic, fibrinopurulent coat that imprisons the lung appears.
An empyema capsule contains pus.

Pleural empyema (empyema pleurae)
Classification :
Size :
 total empyema – entire pleural cavity
 partial empyema ( one compartment, many compartments)
Time :
 acute
 chronic
Iatrogenic:
 preserved lung parenchyma
 postpneumonectomy empyema
With or without broncho-
pleural fistula

Pleural empyema (empyema pleurae)
Clinical signs:
ACUTE PHASE:
 fever (hectic)
 chills
 dyspnoea
 toxememia
 chest pain
 tachypnoë
 weakness
 anorexia
 weight loss
 chst wall infiltration
 WBC elevation
 Anemia
 Expectoration (fistula)


CHRONIC PHASE:
 feverishness
 cachexia
 cough
 dyspnoea
 intercostal space
norrowing
 scoliosis
 chest pain

Pleural epmyemaPleural epmyema

Pleural empyema (empyema pleurae)
TREATMENT :
ACUTE PHASE:
 Antibiotics (IV),
 Pleural pucture,
 Pleural drainage,
 Antibiotics (inside the pleura).

PLEURAL EMPYEMA (empyema pleurae)
TREATMENT :
CHRONIC PHASE:
 Pleural drainage + antibiotics to the pleural cavity.
 Drainage flow
 Open drainage (chest window) after 14 days.
 Fibrinolitics ( streptokinase, streptodornase): local PE.
 VATS (debridement).

PLEURAL EMPYEMA (empyema pleurae)
SURGICAL TREATMENT:
 Thoracotomy and decortication of the lung -
 Decortication of the lung + lung resection
 Thoracostomy (fenestration) – chest window.

PLEURAL EMPYEMA (empyema pleurae)
COMPLICATIONS :
 atelectasis and respiratory insufficiency
 broncho-pleural fistula
 pleuro-cutaneous fistula
 esophageo-pleural fistula
 sepsis
 peritonitis
 metastatic abscesses in liver, kidneys, spleen and other organs.
 chest wall inflamatory infiltration
 progressing respiratory insufficiency

PLEURAL EMPYEMA (empyema pleurae)
PROGNOSIS :
Mortality rate in acute phase: app. 1-19%.
(sepsis).

Chronic phase : Mortality rate in patients with diabetes, cancer,
alcohol abuse is app. 40%.
(respiratory insufficiency, MOF).

BronchiectasisBronchiectasis
DefinitionDefinition: abnormal permanent dilatation of : abnormal permanent dilatation of
subsegmental airwayssubsegmental airways
..
The first description:LaThe first description:Laëënnec in 1819 .nnec in 1819 .
Term bronchiectasis: Hasse in 1846.Term bronchiectasis: Hasse in 1846.
The first successful surgical procedure for The first successful surgical procedure for
bronchiectasis (partial resection of the lung lobe)- bronchiectasis (partial resection of the lung lobe)-
Krause 1898.Krause 1898.

Bronchiectasis: classificationBronchiectasis: classification
Macroscopic picture Macroscopic picture (Reid)(Reid)

CylindricalCylindrical (27%) (27%)

SaccularSaccular (11%) (11%)

Varicose (Mixed)Varicose (Mixed) (62%) (62%)
{Reid L.M.: Reduction in bronchial subdivision in bronchiectases. Thorax 5:233, 1950}{Reid L.M.: Reduction in bronchial subdivision in bronchiectases. Thorax 5:233, 1950}
HoodHood’s classification’s classification

SaccullarSaccullar

CylindricalCylindrical

PseudoPseudobronchiectasesbronchiectases
{Hood R.M.: Bacterial infections of the lungs. General thoracic surgery. {Hood R.M.: Bacterial infections of the lungs. General thoracic surgery.
Baltimore, 1994;930}Baltimore, 1994;930}

Bronchiectases: autopsyBronchiectases: autopsy

Clinical signs and symptoms
 Early stage: no symptoms (20-30 y.)Early stage: no symptoms (20-30 y.)

Female / Male ratio - 2.5 : 1Female / Male ratio - 2.5 : 1

Cought with expectoration: the most common Cought with expectoration: the most common
symptom (75%).symptom (75%).

Clinical signs and symptoms
 Hemophtysis (50%), sometimes massive.Hemophtysis (50%), sometimes massive.

Late sign: clubbed fingers, cachexiaLate sign: clubbed fingers, cachexia

Repeated episodes of respiratory tract Repeated episodes of respiratory tract
infections(33%)infections(33%)

Clubbed fingersClubbed fingers

BronchographyBronchography

Diagnosis

CT: the gold standardCT: the gold standard

Bronchiectasis: CTBronchiectasis: CT

Bronchiectasis: treatmentBronchiectasis: treatment
Conservative: Conservative:
FIRST LINE TREATMENT!!!FIRST LINE TREATMENT!!!
- - AAntntiibiotbioticsics
- - Mucolitic agentsMucolitic agents
- - Postural drainagePostural drainage
- - Breathing exercisesBreathing exercises

Bronchiectasis: surgical treatmentBronchiectasis: surgical treatment
SurgerySurgery
-Indications: Indications:
•conservative treatment failure (reccurent conservative treatment failure (reccurent
symptoms or infection when medication is symptoms or infection when medication is
discontinued)discontinued)
• complications- recurrent hemoptysis, complications- recurrent hemoptysis,
haemorrhagehaemorrhage
- - Aim: resecton of all affected lung tissue, Aim: resecton of all affected lung tissue,
prevention of reccurence.prevention of reccurence.
- - Method: Method: wedge, segmentectomy, wedge, segmentectomy, lobelobecctomtomyy
(pneumone(pneumonecctomtomyy v. rarev. rare)), lung transplantation, lung transplantation

Mycobacterium TuberculosisMycobacterium Tuberculosis

18821882
ROBERT KOCHROBERT KOCH

TuberculosisTuberculosis

TBC infectionTBC infection

Clinical pictureClinical picture
Non-characteristic- very oftenNon-characteristic- very often

Purulent coughPurulent cough

MalaiseMalaise

Weight lossWeight loss

HaemoptysisHaemoptysis

FeverFever

Night sweatsNight sweats

DiagnosisDiagnosis
Tuberculin skin testingTuberculin skin testing

Sputum smear (Ziehl- Neelsen)Sputum smear (Ziehl- Neelsen)

Sputum (bronchoalveolar lavage) culturesSputum (bronchoalveolar lavage) cultures

X-ray examinationX-ray examination

Nucleic acid assay (NAA)Nucleic acid assay (NAA)

PCRPCR

IFN-
Ɣ
IFN-
Ɣ

Tuberculosis: chest X-rayTuberculosis: chest X-ray

Cavernous tuberculosisCavernous tuberculosis

Pulmonary tuberculosis: autopsyPulmonary tuberculosis: autopsy

TREATMENTTREATMENT
Conservative treatment with Conservative treatment with
antitubercuolus drugsantitubercuolus drugs

Surgical treatment approx. Surgical treatment approx. 2%2% of of
casescases

2 million deaths annually worldwide2 million deaths annually worldwide

PHARMACOLOGYPHARMACOLOGY
IsoniazidIsoniazid

RifampinRifampin

PyrazinamidePyrazinamide

StreptomicinStreptomicin

EthambutolEthambutol

Time: 6-9 monthsTime: 6-9 months

Resistance for first line drugs (Isoniazid, Resistance for first line drugs (Isoniazid,
Rifampin, Ethambutol) is a serious problem.Rifampin, Ethambutol) is a serious problem.

SURGICAL TREATMENTSURGICAL TREATMENT
INDICATIONSINDICATIONS
UNEFFECTIVE PHARMACOLOGICAL UNEFFECTIVE PHARMACOLOGICAL
TREATMENT FOR 12 MONTHSTREATMENT FOR 12 MONTHS

COMPLICATIONS OF TUBERCULOSISCOMPLICATIONS OF TUBERCULOSIS

SURGICAL TREATMENT OF SURGICAL TREATMENT OF
COMPLICATIONSCOMPLICATIONS
ABSOLUTE INDICATIONSABSOLUTE INDICATIONS
- - HaemorrhageHaemorrhage
- Pleural empyema with bronchopleural fistula- Pleural empyema with bronchopleural fistula
- Aspergilloma in posttuberculous cavity- Aspergilloma in posttuberculous cavity
- Lymph node compression of the bronchi- Lymph node compression of the bronchi

SURGICAL TREATMENT OF SURGICAL TREATMENT OF
COMPLICATIONSCOMPLICATIONS
RELATIVE INDICATIONSRELATIVE INDICATIONS
- - Posttuberculous cavityPosttuberculous cavity
- - Tuberculoma (carcinoma suspicion, Tuberculoma (carcinoma suspicion,
potential source of tuberculosis potential source of tuberculosis
reactivation)reactivation)
- - Lung completely destroyed by tuberculosisLung completely destroyed by tuberculosis
Tags